# Study of Irinotecan & Capecitabine in Metastatic Colorectal Cancer

> **NCT00506168** · PHASE2 · TERMINATED · sponsor: **National Cancer Center, Korea** · enrollment: 37 (actual)

## Conditions studied

- Colorectal Neoplasms
- Secondary
- Drug Therapy, Combination

## Interventions

- **DRUG:** Irinotecan, Capecitabine

## Key facts

- **NCT ID:** NCT00506168
- **Lead sponsor:** National Cancer Center, Korea
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2001-11
- **Primary completion:** —
- **Final completion:** 2007-07
- **Target enrollment:** 37 (ACTUAL)
- **Why stopped:** The study drugs are not covered anymore by insurance.
- **Last updated:** 2007-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00506168

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00506168, "Study of Irinotecan & Capecitabine in Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00506168. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*